Dr. Ertekin-Taner's Genetics of Alzheimer's Disease and Endophenotypes Laboratory receives funding from these sources.


Investigator & Role Grant Title Funding Source Duration
Nilufer Ertekin-Taner, M.D., Ph.D., site principal investigator Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations (1U19AG074879-01A1) National Institute on Aging 03/2023 - 02/2028
Nilufer Ertekin-Taner, M.D., Ph.D., multiple principal investigators A Systems Approach to Targeting Innate Immunity in AD (U01 AG046139-06 Multiple PD/PI Co-operative Agreement at University of Florida) National Institute on Aging 09/2018 - 08/2023
Nilufer Ertekin-Taner, M.D., Ph.D., principal investigator Harnessing Molecular Networks of Resilience for Therapeutic Discoveries in AD (R01 AG061796) National Institute on Aging 09/2018 - 04/2023